Long-term risks after splenectomy among 8,149 cancer-free American veterans: a cohort study with up to 27 years follow-up
about
Bacterial Infections Following Splenectomy for Malignant and Nonmalignant Hematologic DiseasesA Review of Gaucher Disease Pathophysiology, Clinical Presentation and TreatmentsSpleen Australia guidelines for the prevention of sepsis in patients with asplenia and hyposplenism in Australia and New Zealand.Rituximab salvage therapy in adults with immune thrombocytopenia: retrospective study on efficacy and safety profiles.Balancing Therapy with Thrombopoietin Receptor Agonists and Splenectomy in Refractory Immune Thrombocytopenic Purpura: A Case of Postsplenectomy Thrombocytosis Requiring PlateletpheresisLong-term complications of splenectomy in adult immune thrombocytopenia.Safety and efficacy of romiplostim in splenectomized and nonsplenectomized patients with primary immune thrombocytopenia.A practical guide to the use of eltrombopag in children with chronic immune thrombocytopenia.The efficacy of spleen-preserving distal pancreatectomy with or without splenic vessel preservation: a meta-analysis.Autophagic vesicles on mature human reticulocytes explain phosphatidylserine-positive red cells in sickle cell disease.Increased Risk of Hemorrhagic and Ischemic Strokes in Patients With Splenic Injury and Splenectomy: A Nationwide Cohort StudyBiomechanics of red blood cells in human spleen and consequences for physiology and diseaseMyeloid PTEN deficiency impairs tumor-immune surveillance via immune-checkpoint inhibition.New perspectives on the thrombotic complications of haemolysis.Bilateral lung transplantation in a patient with humoral immune deficiency: a case report with review of the literature.Vaccination coverage and mortality after splenectomy: results from an Italian single-centre study.Review of the Clinical and Economic Burden of Antibody-Mediated Rejection in Renal Transplant Recipients.Review of the Association between Splenectomy and Chronic Thromboembolic Pulmonary Hypertension.Convergence in the Epidemiology and Pathogenesis of COPD and Pneumonia.Laparoscopic splenic artery ligation for hypersplenism in cirrhosis: A case series.Minimally Invasive Approach for Spleen-Preserving Distal Pancreatectomy: a Comparative Analysis of Postoperative Complication Between Splenic Vessel Conserving and Warshaw's Technique.Risk of cardiovascular events and pulmonary hypertension following splenectomy - a Danish population-based cohort study from 1996-2012.Recommendations regarding splenectomy in hereditary hemolytic anemias.Laparoscopic Partial Splenectomy for Unknown Primary Cancer: A Stepwise Approach.Transcription factor TLX1 controls retinoic acid signaling to ensure spleen development.Bloodstream infections in patients with chronic lymphocytic leukemia: a longitudinal single-center study.Splenectomy is an independent risk factor for poorer perioperative outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: an analysis of 936 procedures.Clinical value of spleen-preserving distal pancreatectomy: a case-matched analysis with a special emphasis on the postoperative systemic inflammatory response.Proactive use of eltrombopag before the onset of clinical bleeding in two children with immune thrombocytopenia and lifestyle restrictions.Cannabinoids synergize with carfilzomib, reducing multiple myeloma cells viability and migration.Thromboembolic Events Following Splenectomy: Risk Factors, Prevention, Management and Outcomes.Splenectomy in ITP: we keep removing a healthy functional organ.Synchronous Occurrence of Mycosis Fungoides, Diffuse Large B Cell Lymphoma and Acute Myeloid Leukemia.Efficacy and safety of thrombopoietin receptor agonists in children with chronic immune thrombocytopenia: a meta-analysis.Transitioning patients with immune thrombocytopenia to second-line therapy: Challenges and best practices.Improved Splenic Function After Hematopoietic Stem Cell Transplant for Sickle Cell Disease.Anti-infective vaccination strategies in patients with hematologic malignancies or solid tumors-Guideline of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO).Laparoscopic Spleen-Preserving Distal Pancreatectomy (LSPDP) with Preservation of Splenic Vessels: An Inferior-Posterior ApproachTrial protocol: a multicentre randomised trial of first-line treatment pathways for newly diagnosed immune thrombocytopenia: standard steroid treatment versus combined steroid and mycophenolate. The FLIGHT trialEltrombopag-based combination treatment for immune thrombocytopenia
P2860
Q26778773-D0191116-E5BA-44A0-9A3C-8CE370FF5E19Q30235844-5F61917D-33ED-414F-9542-0281E7CE55ACQ30240287-3662D5B9-A870-41F4-9628-81FE05B389C9Q33431198-B5750C40-96B1-44C5-8D1D-97FF51645D25Q33436521-568E6E07-BE0B-44BB-BDF1-61CB14D3E3BEQ33437227-7CAB8F30-11C3-4262-94CB-CFD5EC84B804Q33441008-38A38763-19CA-4AFD-B7D7-F2A6CA1BC3ADQ33442065-09523AD2-6E30-4B29-AF09-9EA14567F315Q35894844-9817DD29-FEC7-4144-98C4-664ABCE7520CQ36169789-CC6E78DE-564A-4933-806E-FE43E27B12A2Q36194323-6C7B0D8A-52AD-40F1-B82F-AF55CBBD9B4EQ37102400-3B9F9783-C95A-4FA2-B1DA-0099BA2CE616Q37222197-DFD60C23-E531-4E49-8D14-82843642D297Q38259274-6A99A391-9D46-4F49-B2C8-14D41AC261ABQ38266049-A35B543A-9B83-435A-8AFB-DD28116A5120Q38644008-7AD102AD-6459-49FD-82A5-6DD7B4955CD4Q38746225-E51EEFB8-C8BE-40EE-96EC-C9BFE93DE775Q38801779-A56736DF-FC14-499E-A739-E99828533727Q38867042-9B43E5A1-EA63-4DC6-9DE8-13C84E433300Q39716964-0E6DAFAD-2E65-421C-98DE-2583048A447CQ39855014-7A324AA1-F712-4F8A-9F5B-C5FA9F4BF0ADQ40176999-9A36A11B-A530-41AF-BFD8-5421B2DB85CEQ40196891-8CFF1B27-6A18-474B-8091-23BD82795744Q40429399-1008FD86-4322-42F1-A9B5-BCBCF3001839Q40663410-E89E11F4-E38B-45E9-AB56-71E3D43E81A6Q40755934-E3FC4A3C-3E24-486E-B9CE-3B025380C20AQ41598605-4755F011-3313-4DAE-BC27-614716AA77B5Q42216526-4D521FA8-31C3-4AEF-95B1-D47A1E0956F4Q42279524-A5BAF268-FE79-4E44-9948-A35D2B8081A8Q42314593-FE001804-00AE-420C-A490-1524E87D7C25Q47296896-FDDADC1F-8222-4DD7-A48A-B0CCD4691C82Q48088532-0A7CBDBD-343D-4808-89C2-C68DEB3B14FFQ50101634-72D23B58-F6F2-4DEA-89AD-225AE76A45B0Q50224066-093BCEC0-B0EE-46A0-ABFE-8F3259AA389BQ52633900-5D68C29C-9264-4152-995F-E266FBA06053Q52889515-F8A48D6B-4856-44A5-B02E-0E1C997DC0BEQ55364518-7B05F00E-91A2-4646-8CCF-BCF7DDAB3C90Q57300456-07998B8A-5E98-4BF0-ABE7-00F07FBBD494Q57811987-DC5419FD-AA44-436C-B995-B5B8E89392ABQ57818187-A087BE55-9E84-4E12-B73D-BBD852511DDE
P2860
Long-term risks after splenectomy among 8,149 cancer-free American veterans: a cohort study with up to 27 years follow-up
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 September 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Long-term risks after splenect ...... with up to 27 years follow-up
@en
Long-term risks after splenect ...... with up to 27 years follow-up.
@nl
type
label
Long-term risks after splenect ...... with up to 27 years follow-up
@en
Long-term risks after splenect ...... with up to 27 years follow-up.
@nl
prefLabel
Long-term risks after splenect ...... with up to 27 years follow-up
@en
Long-term risks after splenect ...... with up to 27 years follow-up.
@nl
P2093
P2860
P1433
P1476
Long-term risks after splenect ...... with up to 27 years follow-up
@en
P2093
David Check
Gloria Gridley
Robert N Hoover
Sigurdur Y Kristinsson
P2860
P304
P356
10.3324/HAEMATOL.2013.092460
P50
P577
2013-09-20T00:00:00Z